These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4389278)

  • 1. The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro.
    Clineschmidt BV; Horita A
    Biochem Pharmacol; 1969 May; 18(5):1011-20. PubMed ID: 4389278
    [No Abstract]   [Full Text] [Related]  

  • 2. The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--II. Studies in vivo.
    Clineschmidt BV; Horita A
    Biochem Pharmacol; 1969 May; 18(5):1021-8. PubMed ID: 5789770
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.
    Robinson DS; Lovenberg W; Keiser H; Sjoerdsma A
    Biochem Pharmacol; 1968 Jan; 17(1):109-19. PubMed ID: 4384242
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
    Stanton HC; Schwartz A
    Proc West Pharmacol Soc; 1966; 9():6-8. PubMed ID: 4381147
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of monoamine oxidase inhibitors on formation of morphine glucuronide.
    Yeh SY; Mitchell CL
    Biochem Pharmacol; 1972 Feb; 21(4):571-8. PubMed ID: 5014513
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 8. Special application of fluorescence histochemistry: studies on eight monoamine oxidase inhibitors in brain neurons.
    Bartonícek VJ
    Pharmacology; 1970; 4(1):16-24. PubMed ID: 4393462
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase.
    Gorkin VZ; Gridneva LI; Klyashtorin LB; Veryovkina IV; Vina I
    Experientia; 1966 Mar; 22(3):157. PubMed ID: 5960880
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns.
    Collins GG; Youdim MB; Sandler M
    Biochem Pharmacol; 1972 Jul; 21(14):1995-8. PubMed ID: 4405452
    [No Abstract]   [Full Text] [Related]  

  • 12. [ON THE MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS].
    HORNYKIEWICZ O
    Wien Klin Wochenschr; 1964 Apr; 76():289-93. PubMed ID: 14223504
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective brain monoamine oxidase inhibition resulting from an interaction between reversible and irreversible inhibitors.
    Horita A
    Int J Neuropharmacol; 1965 Nov; 4(6):337-42. PubMed ID: 4379937
    [No Abstract]   [Full Text] [Related]  

  • 14. MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS.
    GOLDBERG LI
    JAMA; 1964 Nov; 190():456-62. PubMed ID: 14197995
    [No Abstract]   [Full Text] [Related]  

  • 15. Rates of recovery of irreversibly inhibited monoamine oxidases: a measure of enzyme protein turnover.
    Planz G; Quiring K; Palm D
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):27-42. PubMed ID: 4260803
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection and identification of monoamine oxidase inhibitors in biological samples.
    Curry AS; Mercier M
    Nature; 1970 Oct; 228(5268):281-2. PubMed ID: 5479525
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental observations on the effects of adrenaline after treatment with antidepressant monoamine oxidase inhibitor (MAOI) drugs.
    Trinker FR; Fearn H; McCulloch MW; Rand MJ
    Aust Dent J; 1967 Aug; 12(4):297-303. PubMed ID: 5233628
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Monoamine tetrazolium reductase of rat heart mitochondria.
    Sen R; Parmar SS; Guha SR
    J Pharm Pharmacol; 1973 Oct; 25(10):835-7. PubMed ID: 4149751
    [No Abstract]   [Full Text] [Related]  

  • 19. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
    MAXWELL DR; GRAY WR; TAYLOR EM
    Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.